These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1098684)

  • 1. Procainamide and phenytoin. Comparative study of their antiarrhythmic effects at apparent therapeutic plasma levels.
    Karlsson E
    Br Heart J; 1975 Jul; 37(7):731-40. PubMed ID: 1098684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of intravenous phenytoin, procainamide and practolol in the acute treatment of ventricular arrhythmias.
    Karlsson E; Kinman A; Sonnhag C
    Eur J Clin Pharmacol; 1977; 11(1):1-6. PubMed ID: 832652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: Procainamide and phenytoin: a comparison of two antiarrhythmic drugs.
    Karlsson E; Sievers J
    Br Heart J; 1976 May; 38(5):532. PubMed ID: 1268000
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction.
    Campbell RW; Dolder MA; Prescott LF; Talbot RG; Murray A; Julian DG
    Lancet; 1975 Jun; 1(7919):1257-60. PubMed ID: 48894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction.
    Koch-Weser J; Klein SW; Foo-Canto LL; Kastor JA; DeSanctis RW
    N Engl J Med; 1969 Dec; 281(23):1253-60. PubMed ID: 4900236
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical efficacy of antiarrhythmic drugs in prevention of sudden coronary death.
    Winkle RA
    Ann N Y Acad Sci; 1982; 382():247-57. PubMed ID: 6979282
    [No Abstract]   [Full Text] [Related]  

  • 7. The effectiveness of antiarrhythmic agents on early-cycle premature ventricular complexes.
    Krone RJ; Miller JP; Kleiger RE; Clark KW; Oliver GC
    Circulation; 1981 Mar; 63(3):664-9. PubMed ID: 7006853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative antiarrhythmic efficacy of intravenous N-acetylprocainamide and procainamide.
    Sonnhag C; Karlsson E
    Eur J Clin Pharmacol; 1979 Jun; 15(5):311-7. PubMed ID: 378673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of Kö 1173, a new anticonvulsant agent on experimental cardiac arrhythmias.
    Allen JD; Ekue JM; Shanks RG; Zaidi SA
    Br J Pharmacol; 1972 Aug; 45(4):561-73. PubMed ID: 5085230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic effects of procainamide and phenytoin at apparent therapeutic plasma levels.
    Karlsson E; Sonnhag C
    Eur J Clin Pharmacol; 1976 Sep; 10(5):305-10. PubMed ID: 976303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a long-acting antiarrhythmic agent--QX-572--on therapy resistant ventricular tachyarrhythmias.
    Rydén L; Hjalmarson A; Wasir H; Werkö L
    Br Heart J; 1974 Aug; 36(8):811-21. PubMed ID: 4413111
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary ventricular fibrillation complicating acute myocardial infarction.
    Dhurandhar RW; MacMillan RL; Brown KW
    Am J Cardiol; 1971 Apr; 27(4):347-51. PubMed ID: 5572577
    [No Abstract]   [Full Text] [Related]  

  • 13. Procainamide in the dog: antiarrhythmic plasma concentrations after intravenous administration.
    Papich MG; Davis LE; Davis CA
    J Vet Pharmacol Ther; 1986 Dec; 9(4):359-69. PubMed ID: 3806778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic efficacy of N-acetylprocainamide in patients with premature ventricular contractions.
    Lee WK; Strong JM; Kehoe RF; Dutcher JS; Atkinson AJ
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):508-14. PubMed ID: 776488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrhythmia prophylaxis: Long-term suppressive medication.
    Lovell RR
    Circulation; 1975 Dec; 52(6 Suppl):III236-40. PubMed ID: 52418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative effectiveness of three antiarrhythmic agents in the treatment of ventricular arrhythmias in experimental acute myocardial ischemia.
    Weisse AB; Moschos CB; Passannante AJ; Khan MI; Regan TJ
    Am Heart J; 1971 Apr; 81(4):503-10. PubMed ID: 5552051
    [No Abstract]   [Full Text] [Related]  

  • 17. Agranulocytosis during combined procainamide and phenytoin therapy.
    Crook JE; Woosley RL; Leftwich RB; Natelson EA
    South Med J; 1979 Dec; 72(12):1599-601. PubMed ID: 515773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bretylium tosylate in treatment of refractory ventricular arrhythmias complicating myocardial infarction.
    Terry G; Vellani CW; Higgins MR; Doig A
    Br Heart J; 1970 Jan; 32(1):21-5. PubMed ID: 5417842
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of ventricular arrhythmias after acute myocardial infarct with procaine amide and mexiletine].
    Dolder M; Campbell RW; Talbot RG; Murray A; Prescott LE; Julian DG
    Adv Clin Pharmacol; 1978; 16():59-70. PubMed ID: 356554
    [No Abstract]   [Full Text] [Related]  

  • 20. Arrhythmia prophylaxis with procaine amide: plasma concentrations in relation to dose.
    Collste P; Karlsson E
    Acta Med Scand; 1973 Nov; 194(5):405-11. PubMed ID: 4757219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.